The intravascular ultrasound (IVUS) tools and ancillary equipment market is expected to reach $702 million by 2017, which represents a compound annual growth rate of 7.7 percent from the period from 2012 to 2017, according to a report from Wellesley, Mass.-based BCC Research.
The report suggests that IVUS has "enormous potential in terms of its ability to address unmet requirements in the earlier detection and intervention of coronary artery diseases," and that its popularity is surging because of its superiority to traditional angiography.
While a rising incidence of chronic disease and an aging population base are boosting the IVUS market, the high cost of the devices is helping to restrict it market growth. Consequently, "IVUS is still an underutilized and underpenetrated technology, whose real potential is yet to be exploited," according to the report's authors. Announcement